{"transactions":[{"id":3868489,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":165029,"kind":"person","name":"Garanzini Michael","position":1,"cik":"0001722844","reported_name":"Garanzini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2018-07-12T21:04:07.000Z","date":"2018-07-10","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The restrictions will vest as to one-third (1/3) of the shares on July 10, 2019, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years."}],"balance_after":196250,"source":{"system":"sec-edgar","filing":"0001144204-18-038194","document":"tv498483_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420418038194/tv498483_4.xml","form_type":"4"}},{"id":3960802,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":165029,"kind":"person","name":"Garanzini Michael","position":1,"cik":"0001722844","reported_name":"Garanzini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Warrants (right to buy)","published_at":"2018-04-18T21:24:41.000Z","date":"2018-04-17","kind":"purchase","acquired":true,"shares":156250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities were purchased by the reporting person for a combined purchase price of $0.32 per share of common stock and warrant in connection with the Issuer's public offering that closed on April 17, 2018.  Each warrant will be exercisable during the period commencing on April 17, 2018 and ending on April 17, 2023 at an exercise price of $0.32."}],"balance_after":156250,"derivative":{"exercise_price":0.32,"exercise_date":"2018-04-17","expiration_date":"2023-04-17","underlying":"Common Stock","underlying_shares":156250},"source":{"system":"sec-edgar","filing":"0001144204-18-021207","document":"tv491364_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420418021207/tv491364_4.xml","form_type":"4"}},{"id":3960801,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":165029,"kind":"person","name":"Garanzini Michael","position":1,"cik":"0001722844","reported_name":"Garanzini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2018-04-18T21:24:41.000Z","date":"2018-04-17","kind":"purchase","acquired":true,"shares":156250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities were purchased by the reporting person for a combined purchase price of $0.32 per share of common stock and warrant in connection with the Issuer's public offering that closed on April 17, 2018.  Each warrant will be exercisable during the period commencing on April 17, 2018 and ending on April 17, 2023 at an exercise price of $0.32."}],"balance_after":171250,"source":{"system":"sec-edgar","filing":"0001144204-18-021207","document":"tv491364_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420418021207/tv491364_4.xml","form_type":"4"}},{"id":4152280,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":165029,"kind":"person","name":"Garanzini Michael","position":1,"cik":"0001722844","reported_name":"Garanzini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2017-11-22T21:15:19.000Z","date":"2017-11-17","kind":"grant","acquired":true,"shares":15000,"price":1.07,"value":16050.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.06 to $1.088, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001144204-17-060667","document":"tv480167_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420417060667/tv480167_4.xml","form_type":"4"}},{"id":4157720,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":165029,"kind":"person","name":"Garanzini Michael","position":1,"cik":"0001722844","reported_name":"Garanzini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-11-17T23:53:51.000Z","date":"2017-11-17","kind":"grant","acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on November 1, 2018, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years."}],"balance_after":85000,"derivative":{"exercise_price":1.09,"expiration_date":"2027-11-17","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001144204-17-060013","document":"tv479901_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420417060013/tv479901_4.xml","form_type":"4"}}]}